Media

Bioscience industry a bright spot among the technology sector
The 2014 BIO International Convention, where the global biotech community meets, connecting the people, companies and innovations that help to fulfill the...

Press Releases

Nov 12 1998
(WASHINGTON, D.C., November 12, 1998). . . Carl B Feldbaum, president of the Biotechnology Industry Organization (BIO), today issued the following statement...
Nov 11 1998
(WASHINGTON, D.C., November 11, 1998). . . The Biotechnology Industry Organization (BIO) will host a CEO & Investor Conference in New York Feb. 24-26,...
Oct 27 1998
(WASHINGTON, D.C., October 27, 1998). . . Colorado State Rep.Tony Grampsas (R) has been named the "Outstanding State Legislator of the Year" by the...
Oct 27 1998
(WASHINGTON, D.C., October 27, 1998). . .The Biotechnology Industry Organization (BIO), the largest association of biotechnology companies, state...
Oct 2 1998
(WASHINGTON, D.C., October 2, 1998)...The Biotechnology Industry Organization (BIO) today praised U.S. Rep. Jennifer Dunn (R-Bellevue) of Washington for...
Sep 2 1998
(WASHINGTON, DC, September 2, 1998)...Carl B.Feldbaum, president of the Biotechnology IndustryOrganization (BIO), issued the following statement inresponse...
Aug 12 1998
This week's intense and global publicity given to Dr. Pusztai's work and its implications has led to the Rowett Research Institute's decision to...
Jul 22 1998
WASHINGTON, D.C. (July 22, 1998) - Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO) today issued the following statement on the...
Jul 6 1998
(WASHINGTON, D.C., July 6, 1998)...The Biotechnology Industry Organization (BIO), the largest association of biotechnology companies, state associations and...


Biotechnology News

July 22, 2014

MORRISVILLE, N.C.--(BUSINESS WIRE)--Oxygen Biotherapeutics, Inc. (NASDAQ: OXBT) will host a conference call and live audio webcast on Tuesday, July 29, 2014, at 8:30 a.m....

July 22, 2014

RICHMOND, Va.--(BUSINESS WIRE)--American International Biotechnology, LLC (“AIBioTech”) recently reached a settlement with the U.S. Department of Justice to fully resolve...

July 22, 2014

LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology announced top-line results from the ExteNET study of its investigational drug neratinib, a Phase III trial in adjuvant...

July 22, 2014

LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology announced that its license agreement with Pfizer for the investigational drug neratinib (PB272) has been amended.

July 22, 2014

SAN DIEGO--(BUSINESS WIRE)--La Jolla Pharmaceutical Company Announces Proposed Underwritten Offering of Common Stock